Early inflammatory clinics. Experience with early arthritis/back pain clinics

Clinical and Experimental Rheumatology

Volumn 27, Issue 4 SUPPL. 55, 2009, Pages

  Goëb, Vincent ^a   Smolen, Josef ^b   Emery, Paul ^a   Marzo Ortega, Helena ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Arthritis; Clinic; Early; Low back pain; Rheumatoid arthritis; Spondyloarthritis

Indexed keywords

C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG;

ANKYLOSING SPONDYLITIS; BLOOD CELL COUNT; CLINICAL ASSESSMENT; EARLY DIAGNOSIS; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; GENETIC ANALYSIS; HASHIMOTO DISEASE; HEALTH ASSESSMENT QUESTIONNAIRE; HLA TYPING; HUMAN; INFLAMMATION; LOW BACK PAIN; MORNING STIFFNESS; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PROGNOSIS; PSORIASIS; REMISSION; REVIEW; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SHORT FORM 36; SINGLE NUCLEOTIDE POLYMORPHISM; SJOEGREN SYNDROME; SOCIOECONOMICS; SPONDYLOARTHROPATHY; VISUAL ANALOG SCALE;

ARTHRITIS, RHEUMATOID; EARLY DIAGNOSIS; HUMANS; LOW BACK PAIN; PAIN CLINICS; RHEUMATOLOGY; SPONDYLITIS, ANKYLOSING;

EID: 71249111501     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. EMERY P, MCINNES IB, VAN VOLLENHOVEN R, KRAAN MC: Clinical identification and treatment of a rapidly progressing disease state in patients with rheumatoid arthritis. Rheumatology (Oxford) 2008; 47: 392-398
2. CARBONELL J, COBO T, BALSA A, DESCALZO MA, CARMONA L: The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registry. Rheumatology (Oxford) 2008; 47: 1088-1092
3. NELL-DUXNEUNER V, MACHOLD K, STAMM T et al.: Autoantibody profiling in patients with very early rheumatoid arthritis - a follow-up study. Ann Rheum Dis 2009.
4. GOEB V, THOMAS-L'OTELLIER M, DAVEAU R et al.: Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes. Arthritis Res Ther 2009; 11: R38.
5. GOTTENBERG JE, MIGNOT S, NICAISE-ROLLAND P et al.: Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome. Ann Rheum Dis 2005; 64: 114-117 (Pubitemid 40075286)
6. FABIEN N, OLSSON NO, GOETZ J et al.: Prevalence of autoantibodies to cyclic citrullinated peptide in patients with rheumatic diseases other than rheumatoid arthritis: A French multicenter study. Clin Rev Allergy Immunol 2008; 34: 40-44
7. RICCIO A, POSTIGLIONE L, LA DOGANA P, SPANO A, MARZOCCHELLA C, TARANTINO G: Anti-cyclic citrullinated peptide antibodies in patients affected by HCV-related arthritis. J Biol Regul Homeost Agents 2008; 22: 57-61.
8. DEYO RA, WEINSTEIN JN: Low back pain. N Engl J Med 2001; 344: 363-370
9. HOSKINS W, POLLARD H, DAFF C et al.: Low back pain status in elite and semi-elite Australian football codes: a cross-sectional survey of football (soccer), Australian rules, rugby league, rugby union and non-athletic controls. BMC Musculoskelel Disord 2009; 10: 38.
10. FREBURGER JK, HOLMES GM, AGANS RP et al.: The rising prevalence of chronic low back pain. Arch Intern Med 2009; 169: 251-258
11. DEYO RA, MIRZA SK, MARTIN BI: Back pain prevalence and visit rates: estimates from U.S. national surveys, 2002. Spine 2006; 31: 2724-2727
12. BRAUN J, BOLLOW M, REMLINGER G et al.: Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998; 41: 58-67.
13. UNDERWOOD MR, DAWES P: Inflammatory back pain in primary care. Br J Rheumatol 1995; 34: 1074-1077
14. JENNINGS F, LAMBERT E, FREDERICSON M: Rheumatic diseases presenting as sports-related injuries. Sports Med 2008; 38: 917-930
15. AGGARWAL R, MALAVIYA AN: Diagnosis delay in patients with ankylosing spondylitis: factors and outcomes - an Indian perspective. Clin Rheumatol 2009; 28: 327-331
16. HENSCHKE N, MAHER CG, REFSHAUGE KM et al.: Characteristics of patients with acute low back pain presenting to primary care in Australia. Clin J Pain 2009; 25: 5-11.
17. FELDTKELLER E, KHAN MA, VAN DER HEIJDE D, VAN DER LINDEN S, BRAUN J: Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 2003; 23: 61-66
18. RUDWALEIT M, HAIBEL H, BARALIAKOS X et al.: The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 2009; 60: 717-727
19. RADTKE M, REICH K, BLOME C, RUSTENBACH S, AUGUSTIN M: Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Acad Dermatol Venereol 2009.
20. ALETAHA D, HUIZINGA TW: The use of data from early arthritis clinics for clinical research. Best Pract Res Clin Rheumatol 2009; 23: 117-123
21. BRANDT HC, SPIELER I, SONG IH, VAHLDIEK JL, RUDWALEIT M, SIEPER J: Performance of referral recommendations in patients with chronic back pain and suspected axial spondyloarthritis. Ann Rheum Dis 2007; 66: 1479-1484
22. CUSH JJ: Early arthritis clinic: a USA perspective. Clin Exp Rheumatol 2003; 21 (Suppl. 31): S75-8.
23. QUINN MA, EMERY P: Are early arthritis clinics necessary? Best Pract Res Clin Rheumatol 2005; 19: 1-17.
24. KLARESKOG L, NORDMARK B, LINDBLAD S: On the organization of an early arthritis clinic. Best Pract Res Clin Rheumatol 2001; 15: 1-15.
25. FURUYA T, MATSUMOTO I, TSUCHIYA N et al.: Anti-glucose-6-phosphate isomerase, anti-cyclic citrullinated peptide antibodies and HLA-DRB1 genotypes in Japanese patients with early rheumatoid arthritis. Clin Exp Rheumatol 2008; 26: 918-921
26. MACHOLD KP, EBERL G, LEEB BF, NELL V, WINDISCH B, SMOLEN JS: Early arthritis therapy: rationale and current approach. J Rheumatol Suppl 1998; 53: 13-19
27. EMERY P, BREEDVELD FC, DOUGADOS M, KALDEN JR, SCHIFF MH, SMOLEN JS: Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 2002; 61: 290-297
28. QUINN MA, GREEN MJ, MARZO-ORTEGA H et al.: Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol. Arthritis Rheum 2003; 48: 3039-3045
29. QUINN M, COX S, CONAGHAN P, KEENAN A, HENSOR E, EMERY P: A comparison of 12 Months two standardized therapies on disease activity in an early rheumatoid arthritis: results of the Yorkshire early arthritis register. Arthritis Rheum 2006; 54: S370.
30. GOEB V, DIEUDE P, VITTECOQ O et al.: Association between the TNFRII 196R allele and diagnosis of rheumatoid arthritis. Arthritis Res Ther 2005; 7: R1056-62.
31. COMBE B, BENESSIANO J, BERENBAUM F et al.: The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. Joint Bone Spine 2007; 74: 440-445
32. MACHOLD KP, NELL VP, STAMM TA, EBERL G, STEINER G, SMOLEN JS: The Austrian Early Arthritis Registry. Clin Exp Rheumatol 2003; 21 (Suppl. 31): S113-7.
33. CALIN A, PORTA J, FRIES JF, SCHURMAN DJ: Clinical history as a screening test for ankylosing spondylitis. Jama 1977; 237: 2613-2614
34. GREEN M, MARZO-ORTEGA H, WAKEFIELD RJ et al.: Predictors of outcome in patients with oligoarthritis: results of a protocol of intraarticular corticosteroids to all clinically active joints. Arthritis Rheum 2001; 44: 1177-1183
35. MARZO-ORTEGA H, GREEN MJ, KEENAN AM, WAKEFIELD RJ, PROUDMAN S, EMERY P: A randomized controlled trial of early intervention with intraarticular corticosteroids followed by sulfasalazine versus conservative treatment in early oligoarthritis. Arthritis Rheum 2007; 57: 154-160
36. MARZO-ORTEGA H, MCGONAGLE D, O'CONNOR P et al.: Baseline and one year Magnetic Resonance Imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. The relationship between symptoms, HLA-B27, and disease extent and persistence. Ann Rheum Dis 2008.
37. BENNETT AN, MCGONAGLE D, O'CONNOR P et al.: Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 2008; 58: 3413-3418
38. BOWEN CJ, DEWBURY K, SAMPSON M et al.: Musculoskeletal ultrasound imaging of the plantar forefoot in patients with rheumatoid arthritis: inter-observer agreement between a podiatrist and a radiologist. J Foot Ankle Res 2008; 1: 5.
39. REPPING-WUTS H, REPPING T, VAN RIEL P, VAN ACHTERBERG T: Fatigue communication at the out-patient clinic of Rheumatology. Patient Educ Couns 2008.
40. VAN EIJK Y, BOONEN A, SCHULPEN G, SCHRIJNEMAEKERS V, FIOLET H, VAN DER LINDEN S: Safety and patient satisfaction of infliximab administration in an extramural setting supervised by a rheumatology specialist nurse. Ann Rheum Dis 2006; 65: 276.
41. GLENNAS A, KVIEN TK, MELBY K et al.: Reactive arthritis: a favorable 2 year course and outcome, independent of triggering agent and HLA-B27. J Rheumatol 1994; 21: 2274-80.
42. EGSMOSE C, HANSEN TM, ANDERSEN LS et al.: Limited effect of sulphasalazine treatment in reactive arthritis. A randomised double blind placebo controlled trial. Ann Rheum Dis 1997; 56: 32-36
43. SIDIROPOULOS PI, HATEMI G, SONG IH et al.: Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists. Rheumatology (Oxford) 2008; 47: 355-361
44. HEMMINKI K, LI X, SUNDQUIST J, SUNDQUIST K: Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions. Arthritis Rheum 2009; 60: 661-668
45. GOEB V, DIEUDE P, DAVEAU R et al.: Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis. Rheumatology (Oxford) 2008; 47: 1208-1212
46. HUGLE T, SCHUETZ P, MUELLER B et al.: Serum procalcitonin for discrimination between septic and non-septic arthritis. Clin Exp Rheumatol 2008; 26: 453-456 (Pubitemid 352003215)
47. FOTTNER A, BIRKENMAIER C, VON SCHULZE PELLENGAHR C., WEGENER B, JANSSON V: Can serum procalcitonin help to differentiate between septic and nonseptic arthritis? Arthroscopy 2008; 24: 229-233
48. CARTER JD, GERARD HC, ESPINOZA LR et al.: Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum 2009; 60: 1311-1316
49. FREESTON JE, WAKEFIELD RJ, CONAGHAN PG, HENSOR EM, STEWART SP, EMERY P: A diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power doppler ultrasound when added to conventional assessment tools. Ann Rheum Dis 2009 Apr 27 [Epub ahead of print].
50. MOMENI M, BRINDLE K: MRI for assessing erosion and joint space narrowing in inflammatory arthropathies. Ann N Y Acad Sci 2009; 1154: 41-51.
51. JONES E, CHURCHMAN SM, ENGLISH A et al.: Mesenchymal stem cells in rheumatoid synovium: Enumeration and functional assessment in relation to synovial inflammation level. Ann Rheum Dis 2009 Apr 2 [Epub ahead of print].
52. SALEEM B PR, GOEB V, CONAGHAN PG, EMERY P, PONCHEL F: Early treatment and immunological remission predict long-term biological-free remission post tumour necrosis factor blockers. Ann Rheum Dis 2009; p. A65.
53. BARKHAM N, KEEN HI, COATES LC et al.: Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum 2009; 60: 946-954
54. MANADAN AM, JAMES N, BLOCK JA: New therapeutic approaches for spondyloarthritis. Curr Opin Rheumatol 2007; 19: 259-64.
55. VISVANATHAN S, VAN DER HEIJDE D, DEODHAR A et al.: Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis. Ann Rheum Dis 2009; 68: 175-182